Monte Rosa Therapeutics, Inc. ($GLUE)
Filing Information
| Accession Number | 0001193125-26-290486 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 30, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
18,000
Total Value
$183,060.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Jun 29, 2026 | Exercise/Conversion | 6,000 | $7.56 | $45,360.00 | 65,992 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Jun 29, 2026 | Sale | 6,000 | $22.95 | $137,700.00 | 59,992 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (Right to Buy) | Derivative | Jun 29, 2026 | Exercise/Conversion | 6,000 | $0.00 | $0.00 | 60,000 | Direct | โ | View Details |